These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8548600)
1. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression. Oda Y; Wehrmann B; Radig K; Walter H; Röse I; Neumann W; Roessner A Gen Diagn Pathol; 1995 Oct; 141(2):97-103. PubMed ID: 8548600 [TBL] [Abstract][Full Text] [Related]
2. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Coltrera MD; Wang J; Porter PL; Gown AM Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988 [TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma. Sulzbacher I; Träxler M; Mosberger I; Lang S; Chott A Mod Pathol; 2000 Jun; 13(6):632-7. PubMed ID: 10874667 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors. Kumamoto H; Ooya K J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297 [TBL] [Abstract][Full Text] [Related]
5. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Wang J; Coltrera MD; Gown AM Cancer Res; 1994 Jan; 54(2):560-4. PubMed ID: 7903911 [TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. Majumdar K; Radotra BD; Vasishta RK; Pathak A Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of platelet-derived growth factor and its receptors in soft tissue malignant fibrous histiocytoma. Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Kawamoto T; Hitora T; Nakatani T; Nagira K; Kurosaka M Anticancer Res; 2003; 23(5b):4325-8. PubMed ID: 14666646 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Yacoub L; Goldman H; Odze RD Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315 [TBL] [Abstract][Full Text] [Related]
9. Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Worth LL; Lafleur EA; Jia SF; Kleinerman ES Oncol Rep; 2002; 9(4):823-7. PubMed ID: 12066216 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626 [TBL] [Abstract][Full Text] [Related]
11. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma. Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715 [TBL] [Abstract][Full Text] [Related]
12. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type. Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668 [TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Park HR; Min K; Kim HS; Jung WW; Park YK Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723 [TBL] [Abstract][Full Text] [Related]
14. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259 [TBL] [Abstract][Full Text] [Related]
15. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665 [TBL] [Abstract][Full Text] [Related]
16. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. de Jong JS; van Diest PJ; van der Valk P; Baak JP J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic modification of human osteosarcoma cells with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Ringbom-Anderson T; Sandberg M; Andersson G; Akerman KE Cell Growth Differ; 1995 Apr; 6(4):457-64. PubMed ID: 7794813 [TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Oda Y; Sakamoto A; Shinohara N; Ohga T; Uchiumi T; Kohno K; Tsuneyoshi M; Kuwano M; Iwamoto Y Clin Cancer Res; 1998 Sep; 4(9):2273-7. PubMed ID: 9748149 [TBL] [Abstract][Full Text] [Related]